Streetbeat News

Earnings

Procter & Gamble (NYSE:PG) is set to release its latest quarterly earnings report on July 28, 2023. Analysts estimate an earnings per share (EPS) of $1.19. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $153.94, up 10.6% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:01 pm

SNY

Sanofi (NASDAQ:SNY) is set to release its quarterly earnings report on 2023-07-28, with analysts estimating an EPS of $1.58. The company's past performance shows a correlation between EPS and share price. Last quarter, Sanofi missed EPS by $0.71, resulting in a 4.35% drop in share price. The company's shares are currently trading at $53.51, up 8.0% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:01 pm

AZN

AstraZeneca (NASDAQ:AZN) is set to release its quarterly earnings report on 2023-07-28, with analysts estimating an EPS of $0.95. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. As of July 26, AstraZeneca's shares were trading at $69.38, up 4.11% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:01 pm

HSY

Hershey Co (NYSE:HSY) reported Q2 FY23 sales growth of 5% YoY to $2.49 billion, slightly missing the consensus of $2.50 billion. The company's North America Confectionery segment net sales rose 4.4% YoY, and International segment sales increased 8.5%. Gross margin expanded to 45.5%, and gross profit rose 13.2% YoY. Adjusted EPS of $2.01 beat the analyst consensus of $1.91. The company also announced a 15% increase in quarterly dividends. Hershey raised its FY23 adjusted EPS growth outlook and expects net sales growth of 8%.

Portfolio Pulse from Shivani Kumaresan

July 27, 2023 | 1:51 pm

AAPL

META

SNAP

Meta Platforms reported double-digit revenue growth for Q4 2021 and better than expected Q3 guidance, causing its stock to rise 7% in extended trading. The company's net income rose to $7.79 billion, with earnings per share of $2.98, exceeding Refinitiv's expectations. However, the Reality Labs unit is still struggling, posting a loss of $3.7 billion. Meta's CEO, Mark Zuckerberg, has initiated cost-saving efforts, including 21,000 job cuts.

Portfolio Pulse from Upwallstreet

July 27, 2023 | 1:48 pm

ASXC

CTCX

MNK

MRSN

ULBI

YELL

US stocks traded higher following the release of major economic reports. The US economy grew by an annualized 2.4% in Q2, higher than market estimates of 1.8%. Carmell Therapeutics Corporation (CTCX), Mallinckrodt plc (MNK), and Ultralife Corporation (ULBI) saw their shares rise significantly. However, Mersana Therapeutics (MRSN), Yellow Corporation (YELL), and Asensus Surgical (ASXC) saw their shares drop.

Portfolio Pulse from Lisa Levin

July 27, 2023 | 1:45 pm

ABBV

An executive from AbbVie has announced during a conference call that the company has increased its sales outlook for neuroscience drugs by $300 million, projecting a total of $7.7 billion by 2023.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:43 pm

STM

STMicroelectronics NV reported Q2 FY23 revenue growth of 12.7% YoY to $4.33 billion, beating consensus of $4.27 billion. However, EPS of $1.06 missed the consensus of $1.08. The company saw growth across all segments, with the Automotive and Discrete Group (ADG) revenue rising 34.4% YoY. The company also expanded its margins and revised its FY23 revenues outlook to $17.25 billion - $17.55 billion. STM shares traded higher by 6.82%.

Portfolio Pulse from Anusuya Lahiri

July 27, 2023 | 1:42 pm

ABBV

During a conference call, an executive from AbbVie announced that the company has increased its 2023 sales outlook for Sykrizi by $200 million, bringing the total to $7.6 billion.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:42 pm

DIA

IWM

QQQ

SPY

Major indexes have risen due to positive US economic data and strong earnings reports from several companies.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:40 pm